Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foshan Nanhai Zhongnan Pharmaceutical
Foshan, Guangdong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
The company is a commercial API manufacturer with at least one product (eugenol) approved in China and distributed for pancreatic cancer and related indications.
- Therapeutic areas
- OncologyEndocrinologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Guangzhou Pharmaceutical Holdings LimitedBaiyunshan He Ji Gong Pharmaceutical FactoryGuangzhou Baiyunshan Xingqun PharmaceuticalLiangjiefu (Guangdong) PharmaceuticalBeijing Yiling PharmaceuticalHaw Par Corporation
Beyond the preview
Go deeper on Foshan Nanhai Zhongnan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Foshan Nanhai Zhongnan Pharmaceutical.